AID-CXR: AI Assisted Detection of Chest X-Rays

Sponsor
Oxford University Hospitals NHS Trust (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06075836
Collaborator
(none)
33
1
1
32.4

Study Details

Study Description

Brief Summary

This study has been added as a sub study to the Simulation Training for Emergency Department Imaging 2 study (ClinicalTrials.gov ID NCT05427838).

The Lunit INSIGHT CXR is a validation study that aims to assess the utility of an Artificial Intelligence-based (AI) chest X-ray (CXR) interpretation tool in assisting the diagnostic accuracy, speed, and confidence of a varied group of healthcare professionals. The study will be conducted using 500 retrospectively collected inpatient and emergency department CXRs from two United Kingdom (UK) hospital trusts. Two fellowship trained thoracic radiologists will independently review all studies to establish the ground truth reference standard. The Lunit INSIGHT CXR tool will be used to analyze each CXR, and its performance will be measured against the expert readers. The study will evaluate the utility of the algorithm in improving reader accuracy and confidence as measured by sensitivity, specificity, positive predictive value, and negative predictive value. The study will measure the performance of the algorithm against ten abnormal findings, including pulmonary nodules/mass, consolidation, pneumothorax, atelectasis, calcification, cardiomegaly, fibrosis, mediastinal widening, pleural effusion, and pneumoperitoneum. The study will involve readers from various clinical professional groups with and without the assistance of Lunit INSIGHT CXR. The study will provide evidence on the impact of AI algorithms in assisting healthcare professionals such as emergency medicine and general medicine physicians who regularly review images in their daily practice.

Study Design

Study Type:
Observational
Anticipated Enrollment :
33 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Utility of an AI-based CXR Interpretation Tool in Assisting Diagnostic Accuracy, Speed, and Confidence of Healthcare Professionals: a Study Using 500 Retrospectively Collected Inpatient and Emergency Department CXRs From Two UK Hospital Trusts
Anticipated Study Start Date :
Oct 31, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Readers/Participants

Reader Selection: 30 readers will be selected from the following five clinical specialty groups: emergency medicine (ED) adult intensive care (ICU) adult general medicine (AGM) radiographers (Rad) general radiologists Each specialty group consists of 6 members of ranked seniority. For the physicians this consists of: Two 'Juniors' (Foundation Year 1 - Specialty Training 2 years) Two 'Middle Grades' (Registrar from Specialty Training 3 to 6 years) Two Consultants For the radiographers, this consists of: Two 'Junior/Newly qualified radiographers' (up to 18 months experience post qualification) Two 'Mid-experience radiographers' (approx. 3 years' experience) Two 'Reporting radiographers' (5+ years' experience)

Other: Cases reading
The reading will be done remotely via the Report and Image Quality Control site (www.RAIQC.com), an online platform allowing medical imaging viewing and reporting. Participants can work from any location, but the work must be done from a computer with internet access. For avoidance of doubt, the work cannot be performed from a phone or tablet. The project is divided into two phases and participants are required to complete both phases. The estimated total involvement in the project is up to 20-24 hours. Phase 1: Time allowed: 2 weeks - Review 500 chest X-rays and express a clinical opinion through a structured reporting template (multiple choice, no open text required). Rest/washout period of 2 weeks. Phase 2 - Time allowed: 2 weeks - Review 500 chest X-rays together with an AI report for each case and express your clinical opinion through the same structured reporting template used in Phase A.

Ground truthers

Two consultant thoracic radiologists. A third senior thoracic radiologist's opinion (>20 years experience) will undertake arbitration.

Other: Ground truthing
Two consultant thoracic radiologists will independently review the images to establish the 'ground truth' findings on the CXRs, where a consensus is reached this will then be used as the reference standard. In the case of disagreement, a third senior thoracic radiologist's opinion (>20 years experience) will undertake arbitration. A difficulty score will be assigned to each abnormality by the ground truthers using a 4-point Likert scale (1 being easy/obvious to 4 being hard/poorly visualised).

Outcome Measures

Primary Outcome Measures

  1. Performance of AI algorithm: sensitivity [During 4 weeks of reading time]

    Evaluation of the Lunit INSIGHT CXR algorithm will be performed comparing it to the reference standard in order to determine sensitivity.

  2. Performance of AI algorithm: specificity [During 4 weeks of reading time]

    Evaluation of the Lunit INSIGHT CXR algorithm will be performed comparing it to the reference standard in order to determine specificity.

  3. Performance of AI algorithm: Area under the ROC Curve (AU ROC) [During 4 weeks of reading time]

    Evaluation of the Lunit INSIGHT CXR algorithm will be performed comparing it to the reference standard. Continuous probability score from the algorithm will be utilized for the ROC analyses, while binary classification results with a predefined operating cut-off will be used for evaluation of sensitivity, specificity, positive predictive value, and negative predictive value.

  4. Performance of readers with and without AI assistance: Sensitivity [During 4 weeks of reading time]

    The study will include two sessions (with and without AI overlay), with all 30 readers reviewing all 500 CXR cases each time separated by a washout period to mitigate recall bias. The cases will be randomised between the two reads and for every reader.

  5. Performance of readers with and without AI assistance: Specificity [During 4 weeks of reading time]

    The study will include two sessions (with and without AI overlay), with all 30 readers reviewing all 500 CXR cases each time separated by a washout period to mitigate recall bias. The cases will be randomised between the two reads and for every reader.

  6. Performance of readers with and without AI assistance: Area under the ROC Curve (AU ROC) [During 4 weeks of reading time]

    The study will include two sessions (with and without AI overlay), with all 30 readers reviewing all 500 CXR cases each time separated by a washout period to mitigate recall bias. The cases will be randomised between the two reads and for every reader.

  7. Reader speed with vs without AI assistance. [During 4 weeks of reading time]

    Mean time taken to review a scan, with vs without AI assistance.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • General radiologists/radiographers/physicians who review CXRs as part of their routine clinical practice
Exclusion Criteria:
  • Thoracic radiologists

  • Non-radiology physicians with previous formal postgraduate CXR reporting training.

  • Non-radiology physicians with previous career in radiology, respiratory medicine or thoracic surgery to registrar or consultant level

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oxford University Hospitals NHS Foundation Trust Oxford Oxfordshire United Kingdom OX3 9DU

Sponsors and Collaborators

  • Oxford University Hospitals NHS Trust

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Alex Novak, Primary Investigator, Oxford University Hospitals NHS Trust
ClinicalTrials.gov Identifier:
NCT06075836
Other Study ID Numbers:
  • 310995 - B
First Posted:
Oct 10, 2023
Last Update Posted:
Oct 10, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Alex Novak, Primary Investigator, Oxford University Hospitals NHS Trust
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 10, 2023